Buy, Sell or Hold: Lemonade (LMND-N)

Home

Daily Stock Opinions and Ratings

Lemonade (LMND-N)

42.13

+1.40 (3.44%)

as of Jul 18, 2025, 8:00:00 pm Market Open.

49 watching

Nervous markets await Nvidia

Investor Insights

Apr 16, 2025, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Lemonade Inc. (LMND) has shown significant growth, with an impressive increase of 58% over the past year. However, experts note that the company remains relatively small and continues to operate at a loss, making it a risky and volatile investment. There are indications of the stock being in a massive short squeeze, which could continue for a while and possibly present short-term profit-taking opportunities. Despite its potential, experts highlight that LMND does not pay dividends and is not considered a conservative investment option. Therefore, individuals interested in this stock should carefully evaluate their investment profile and risk tolerance prior to making any decisions.

Consensus

Mixed

Valuation

Overvalued

Similar

Roket, RKT

DON'T BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

LMND has done well, up 58% in the past year. But it is fairly small, losing money, pays no dividend and is risky/volatile. We do not have anything against it really but it is not a conservative stock and it depends on an investors' profile. We would not see it as a need-to-own name.
Unlock Premium - Try 5i Free

WAIT

Numbers were okay, but they're in a giant short squeeze that will continue. Will till Friday then maybe take some profits.

HOLD

Artificial intelligence insurance company. Company shares have been hit very hard with tech selloff. Hoping to replace human element in insurance business. Burning through a lot of cash the next 2-4 years. Wants to see more cash flow before investing. Rising interest rates will negatively impact this business. Better options for investors.

WEAK BUY

Likes it. Has it in some separately managed accounts willing to take on more risk. Only pure play insurance tech in the market. Produces its own software. Recently into auto insurance. Decent size. Good runway. (Analysts’ price target is $32.63)

WEAK BUY

Poster child for SaaS that's struggled this year. 12-month price target of $65.50. Long runway, but unprofitable. Rising interest rates contract the multiple. The only pure play insurance start up. Buy it here just under $40, with a close stop of $35.

HOLD

Going into earnings, don't buy any more. That said, the stock has come down enough and won't anymore.

COMMENT

Problem is, they offer a great product, but it's hard to determine the value of the stock. Also, this is heavily shorted so it's volatile (not a Reddit stock though). He likes it, but you'll have to wait for the value of the stock to catch up with the value proposition.

DON'T BUY

2020 IPOs cost too much, and are worth buying now that they are out of style and cheaper. This insurance disruptor was worth buying below $50, which happened two months after its IPO. Then, it took off, but down 50% from its peak now. He loves this company, but they're losing tons of money and the stock trades at 50x sales (not earnings).

COMMENT

An AI-powered insurance broker. 11% of shares were just shorted. They report Monday.

PARTIAL SELL

Lemonade is an A.I. insurer and disruptor. He likes it. Lemonade shot up before Christmas, but plunged 14% Dec. 28 right before its next lock-up expired the following day. The company had traded only 11 million of a total 57 million as listed in their IPO. They unlocked 15 million in November, then 30 million more in late December. Heavy volatility followed to present. Then an investing article spurred a huge short squeeze. It now trades at absurd levels. Take profits here and don't tempt fate.

COMMENT

It's a disruptive tech play on insurance, but also a puzzle. It stormed out of the gate as its IPO rose too high in late June. He waited for a pullback, that happened, and recently it's been rangebound. Despite a top- and bottom-line beat today, it sold off. He doesn't get it.

BUY

They report next week and he expects good results when they report next. A new company that uses AI to shake up the insurance industry.

BUY ON WEAKNESS

What he calls one of 15 Red Hot stocks: unstoppable growth stocks with a sky-high valuation (30-100x sales, not earnings) It's trying to revolutionize the insurance industry. He recommended a pullback to $60, which it is fallen to now. You can buy it now, or wait till it falls further, to $50.

BUY

He likes it. It went public on July 2, and ran up in price quickly. It's a digitized insurance company, and why not in an age where so much is digitized?

TOP PICK

His price target is $96. It was an IPO a couple of weeks ago that came out at $29. It is the only pure insurance start-up tech in the market presently. It does searches for insurance for home owners and renters. Put it on your radar -- only put down 20% of what you are willing to risk and be prepared to buy more at every $10 lower. It is a disruptor in the huge insurance industry. Yield 0%.

Showing 1 to 15 of 15 entries

Lemonade(LMND-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Lemonade is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Lemonade(LMND-N) Frequently Asked Questions

What is Lemonade stock symbol?

Lemonade is a American stock, trading under the symbol LMND-N on the New York Stock Exchange (LMND). It is usually referred to as NYSE:LMND or LMND-N

Is Lemonade a buy or a sell?

In the last year, 1 stock analyst published opinions about LMND-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Lemonade.

Is Lemonade a good investment or a top pick?

Lemonade was recommended as a Top Pick by on . Read the latest stock experts ratings for Lemonade.

Why is Lemonade stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Lemonade worth watching?

1 stock analyst on Stockchase covered Lemonade In the last year. It is a trending stock that is worth watching.

What is Lemonade stock price?

On 2025-07-18, Lemonade (LMND-N) stock closed at a price of $42.13.

Most Recent Experts

Lyle Stein

Forvest Global Wealth Management

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

David Burrows

Barometer Capital Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Lemonade (LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N)

Lemonade(LMND-N) Rating

Lemonade(LMND-N) Frequently Asked Questions

What is Lemonade stock symbol?

Is Lemonade a buy or a sell?

Is Lemonade a good investment or a top pick?

Why is Lemonade stock dropping?

Is Lemonade worth watching?

What is Lemonade stock price?

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Lyle Stein

Jenny Harrington, CEO, Gilman Hill Asset Management

Kevin Simpson

David Burrows

The Panic-Proof Portfolio (Stockchase Research)